Notification

🚨 Trading Holiday 🚨

The NSE and BSE will remain closed for trading and settlement on Friday, April 18, 2025, on account of Good Friday.

Open a Free Demat Account

Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.

Trade Now, Pay Later with up to 4x

Never miss a good trading opportunity due to low funds with our MTF feature.

Track Market Movers Instantly

Stay updated with real-time data. Get insights at your fingertips.

NSE BSE

Trade Nowopens in a new tab

Clinitech Laboratory Limited Share Price

₹ 40.5 0.00 (0.00%)

Apr 11 2025 12:00 AM Healthcare NSE: CTLLAB

Clinitech Laboratory Limited Share Price Update

As of the latest trading session, Clinitech Laboratory Limited share price is currently at 40.5, which is up by 0.00 from its previous closing. Today, the stock has fluctuated between 40.50 and 40.50. Over the past year, Clinitech Laboratory Limited has achieved a return of -66.45 %. In the last month alone, the return has been -26.71 %. Read More...

Clinitech Laboratory Limited Performance

Day Range

Low40.50 High40.50

40.50

52 Week Range

Low 38.23 High 120.75

40.50

Clinitech Laboratory Limited Share Price

544220

CTLLAB

Compare to down-arrow

View

Display

Studies

No Data Available

Open Price

40.50 Prev. Close

40.50 Volume (Shares)

1200.00

Total traded value

.48

Upper Circuit

42.52 Lower Circuit

38.48

Note: The current prices & values are delayed, Loginopens in a new tab to your account for live updates.

Clinitech Laboratory Limited Fundamentals

(Standalone)

Market Cap (Cr)	9.20
PE Ratio (TTM)	24.85
Book Value / Share	40.88
Beta	0.89

ROE	12.48%
EPS (TTM)	1.59
Dividend Yield	0.00%
Net Profit Qtr (Cr)	0.00

Clinitech Laboratory Limited Financials

Key Results
Key Ratios
Balance sheet
Cash Flow
Competition

Revenue

Net income

Particulars	MAR 2024 (Values in Cr)
Revenue	6.40
Operating Expense	5.93
Net Profit	0.37
Net Profit Margin (%)	5.78
Earnings Per Share (EPS)	2.21
EBITDA	1.02
Effective Tax Rate (%)	25.49

Particulars	MAR 2023 (Values in Cr)
Revenue	6.35
Operating Expense	5.50
Net Profit	0.61
Net Profit Margin (%)	9.60
Earnings Per Share (EPS)	4.09
EBITDA	1.36
Effective Tax Rate (%)	29.06

Particulars	MAR 2022 (Values in Cr)
Revenue	6.38
Operating Expense	5.76
Net Profit	0.51
Net Profit Margin (%)	7.99
Earnings Per Share (EPS)	3.42
EBITDA	1.14
Effective Tax Rate (%)	27.14

Particulars	MAR 2021 (Values in Cr)
Revenue	4.55
Operating Expense	4.06
Net Profit	0.40
Net Profit Margin (%)	8.79
Earnings Per Share (EPS)	6.04
EBITDA	0.88
Effective Tax Rate (%)	25.45

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	21.12
ROE %	12.48
ROCE %	12.25
Total Debt to Total Equity	0.32
EBITDA Margin	16.09

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	15.87
ROE %	28.84
ROCE %	23.60
Total Debt to Total Equity	0.45
EBITDA Margin	21.73

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	12.32
ROE %	31.48
ROCE %	31.15
Total Debt to Total Equity	0.44
EBITDA Margin	17.87

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	20.86
ROE %	28.78
ROCE %	30.69
Total Debt to Total Equity	0.38
EBITDA Margin	19.12

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	0.70
Total Assets	5.60
Total Liabilities	5.60
Total Equity	3.54
Share Outstanding	1680000
Price to Book Ratio	0.00
Return on Assets (%)	6.61
Return on Capital (%)	8.42

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	0.78
Total Assets	6.03
Total Liabilities	6.03
Total Equity	2.38
Share Outstanding	1500000
Price to Book Ratio	0.00
Return on Assets (%)	10.16
Return on Capital (%)	17.98

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	0.10
Total Assets	3.68
Total Liabilities	3.68
Total Equity	1.84
Share Outstanding	1500000
Price to Book Ratio	0.00
Return on Assets (%)	13.90
Return on Capital (%)	18.75

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	0.32
Total Assets	2.73
Total Liabilities	2.73
Total Equity	1.39
Share Outstanding	666666
Price to Book Ratio	0.00
Return on Assets (%)	14.72
Return on Capital (%)	20.88

Particulars	MAR 2024 (Values in Cr)
Net Income	0.50
Cash from Operations	0.25
Cash from Investing	-0.63
Cash from Financing	0.44
Net change in Cash	-0.08
Free Cash Flow	1.46

Particulars	MAR 2023 (Values in Cr)
Net Income	0.86
Cash from Operations	1.54
Cash from Investing	-0.65
Cash from Financing	0.08
Net change in Cash	0.67
Free Cash Flow	1.82

Particulars	MAR 2022 (Values in Cr)
Net Income	0.70
Cash from Operations	1.16
Cash from Investing	-1.46
Cash from Financing	0.29
Net change in Cash	-0.21
Free Cash Flow	2.67

Particulars	MAR 2021 (Values in Cr)
Net Income	0.54
Cash from Operations	0.53
Cash from Investing	0.54
Cash from Financing	-0.87
Net change in Cash	0.04
Free Cash Flow	0.71

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
APOLLO HOSPITALS ENTER. L	6902.85	75.76	13.24	99252.39	5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED	86.70	211.46	5.44	162.49	51.01 / 107.94
SHREE PACETRONIX LTD.	71.54	14.90	1.91	25.75	61.11 / 268.50
TRANSGENE BIOTEK LTD.	3.72	0.00	2.60	28.19	3.22 / 10.84
VIMTA LABS LIMITED	1018.75	37.26	6.60	2265.14	420.00 / 1183.00

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
APOLLO HOSPITALS ENTER. L	6902.85	82.59	12.11	99252.39	5690.80 / 7545.10
Surlux Diagnostic Ltd	1.40	0.84	0.13	0.49	0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL	32.42	0.00	-17.36	24.22	28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA	5586.25	29.61	6.27	6111.36	3750.00 / 6400.00

Technicals

EMA & SMA
Resistance and Support
Price Change Analysis

Bullish Moving Averages -

Bearish Moving Averages -

5 Days 40.50
26 Days 49.30
10 Days 41.90
50 Days 57.80
12 Days 42.70
100 Days 69.50
20 Days 46.50
200 Days 74.00

40.50
PIVOT

First Resistance	40.50
Second Resistance	40.50
Third Resistance	40.50

First Support	40.50
Second Support	40.50
Third Support	40.50

RSI	35.17
MACD	-6.58
Commodity Channel Index (CCI)	-63.01

ADX	33.89
Williams % R	-66.47

Clinitech Laboratory Limited Future

Future: Price

25 May

0 100 200 300 400 500 600

Discount/Premium

25 May

0 1 2 3 4 5 6 7

Active Calls

25 May

0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul

0 500 1000 1500 2000 2500

Stock Holding

View Live Stock Screeners

Holding

Public

38.1 Promoter Holdings

61.57 FII

0.31 DII

0.0 Promoter Shares(Pledge Percentage)

0.0

Name	Category	Shares	Shares%
Jyoti Jagdish Nayak	Shareholding of Promoter and Promoter Group	675000.0	29.57
Jagdish Umakant Nayak	Shareholding of Promoter and Promoter Group	674500.0	29.55
Santosh Gopalkrishna Kudva	Public Shareholding	141600.0	6.2
Siddhesh Anant Nayak	Shareholding of Promoter and Promoter Group	55500.0	2.43
Ajit Sakharam Kandar	Public Shareholding	51200.0	2.24
Vishal Ashok Talreja	Public Shareholding	30000.0	1.31
Sanjay Harshadrai Mehta	Public Shareholding	30000.0	1.31
Mukesh Thumar	Public Shareholding	26600.0	1.17
Ananya Jagdish Nayak	Shareholding of Promoter and Promoter Group	100.0	0.0
Eshwari Anant Nayak	Shareholding of Promoter and Promoter Group	100.0	0.0
Ashutosh Jagdish Nayak	Shareholding of Promoter and Promoter Group	100.0	0.0
Anant Umakant Nayak	Shareholding of Promoter and Promoter Group	100.0	0.0

Clinitech Laboratory Limited

Ex-Date	Dividend Amt.	Dividend Type	Record Date	Instrument Type

Learn More About Stocks

Oil India Wins 9 Blocks in OALP Round-IX, Acreage Jumps 85%

Oil India secures 9 exploration blocks in OALP Round-IX, expanding its acreage by 85% to 1.10 lakh sq km. ONGC, Cairn, and BP also win key bids.

16 Apr, 2025 | 3 Min. read

IndusInd Bank Finds ₹1,979 Crore Net Worth Hit in Derivatives Audit

An external audit reveals ₹1,979 crore impact on IndusInd Bank’s net worth due to derivative discrepancies. Bank to reflect changes in FY25 financial reports.

16 Apr, 2025 | 2 Min. read

ICICI Lombard Q4 Profit Falls 1.9%, Declares ₹7 Final Dividend

ICICI Lombard Q4 net profit declines by 1.9% YoY to ₹509.6 crore, while FY25 PAT jumps 30.7%. Board declares ₹7 final dividend, total ₹12.5 for FY25.

16 Apr, 2025 | 3 Min. read

CCI Approves Aster DM–Quality Care Merger; New Entity Named Aster DM Quality Care

CCI clears merger of Aster DM Healthcare and Quality Care India Ltd, forming Aster DM Quality Care Ltd. Combined entity to operate 38 hospitals with 10,150 beds.

16 Apr, 2025 | 3 Min. read

Dr Reddy’s Denies Workforce Reduction Claims Amid Cost-Cut Rumours

Dr Reddy’s Laboratories rejects claims of reducing workforce costs by 25%, asserting no such plans or internal directives.

15 Apr, 2025 | 3 Min. read

Glenmark, Sun Pharma, Zydus Recall Drugs in US over Compliance Issues

Glenmark, Sun Pharma, and Zydus recall multiple drug batches in the US following manufacturing deviations and contamination concerns as per USFDA enforcement reports.

15 Apr, 2025 | 3 Min. read

HAL Denies Selecting PwC for R&D Benchmarking Amid Ongoing Bids

HAL clarifies no consultancy firm has been finalised for R&D benchmarking amid social media buzz about PwC. Selection process still ongoing via GeM portal.

15 Apr, 2025 | 3 Min. read

Aurobindo Pharma Gets USFDA Nod for Generic Xarelto 2.5mg Tablets

Aurobindo Pharma receives USFDA approval to launch generic Xarelto 2.5mg in Q1 FY26, targeting $447 million US market; higher strengths also gain tentative nod.

15 Apr, 2025 | 3 Min. read

IndiGo Becomes World’s Most Valuable Airline With $23.4 Billion Market Cap

IndiGo surpasses global peers to become the most valuable airline by market cap at $23.4 billion, pushing InterGlobe Aviation share price to record highs in 2025.

11 Apr, 2025 | 3 Min. read

SRF Ltd. Commissions New Agrochemical Unit in Dahej Worth Rs.239 Crore

SRF Ltd. starts new agrochemical facility in Dahej, Gujarat with Rs.239 crore investment. Phase 1 operational, full commissioning set for April 2025.

11 Apr, 2025 | 3 Min. read

About Clinitech Laboratory Limited

Companies Owned by Clinitech Laboratory Limited

We have something for everyone

Explore More Investment Options

Start Investing

Stocks

Secure and enhance your financial future today

Invest

IPOs

Your gateway to future financial opportunities

Invest

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x

Invest

US Stocks

Discover opportunities to invest in elite FAANG stocks

Invest

Frequently Asked Questions

What is the Share Price of Clinitech Laboratory Ltd?

Answer Field: The share price of Clinitech Laboratory Ltd for NSE is ₹ 0.00 and for BSE is ₹ 40.50.

What is the Market Cap of Clinitech Laboratory Ltd?

Answer Field: The market cap of Clinitech Laboratory Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 9.20 Cr. as of now.

What is the 52 Week High and Low of Clinitech Laboratory Ltd?

Answer Field: The 52 Week High and Low of Clinitech Laboratory Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 120.75 and ₹ 38.23.

How to Buy Clinitech Laboratory Ltd share?

Answer Field: You can trade in Clinitech Laboratory Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Clinitech Laboratory Ltd?

Answer Field: The 1 year returns on the stock has been -66.45%.

What is the Current Share Price of Clinitech Laboratory Ltd?

Answer Field: Clinitech Laboratory Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 40.50 as on Apr 11 2025 12:00 AM.

What is the Market Cap of Clinitech Laboratory Ltd Share?

Answer Field: The market cap of Clinitech Laboratory Ltd for NSE ₹ 0.0 & for BSE ₹ 9.20 as on Apr 11 2025 12:00 AM.

What is the P/E Ratio of Clinitech Laboratory Ltd Share?

Answer Field: As on Apr 11 2025 12:00 AM the price-to-earnings (PE) ratio for Clinitech Laboratory Ltd share is 24.85.

What is the PB ratio of Clinitech Laboratory Ltd Share?

Answer Field: As on Apr 11 2025 12:00 AM, the price-to-book (PB) ratio for Clinitech Laboratory Ltd share is 40.88.

How to Buy Clinitech Laboratory Ltd Share?

Answer Field: You can trade in Clinitech Laboratory Ltd shares with Bajaj Broking by opening a demat accountopens in a new tab.

How to Buy Clinitech Laboratory Ltd Share on Bajaj Broking App?

Answer Field

To buy Clinitech Laboratory Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Clinitech Laboratory Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Scan to download

Download from App Store

Download from Play Store

9.5 lakh+ Users

4+ App Rating

4 Languages

₹4400+ Cr MTF Book

Open Demat Account

🚨 Trading Holiday 🚨

Open a Free Demat Account

Trade Now, Pay Later with up to 4x

Track Market Movers Instantly

Clinitech Laboratory Limited Share Price

Clinitech Laboratory Limited Share Price Update

Clinitech Laboratory Limited Performance

Day Range

52 Week Range

Clinitech Laboratory Limited Share Price

Open Price

40.50

Prev. Close

40.50

Volume (Shares)

1200.00

Total traded value

.48

Upper Circuit

42.52

Lower Circuit

38.48

Clinitech Laboratory Limited Fundamentals

Clinitech Laboratory Limited Financials

Revenue

Net income

Technicals

Over 1 Month

-26.71

Over 3 Months

-39.32

Over 6 Months

-44.13

Over 1 Year

-66.45

Over 3 Years

0.00

Over 5 Years

0.00

Clinitech Laboratory Limited Future

Future: Price

Discount/Premium

Active Calls

Active Puts

Clinitech Laboratory Limited Shareholding Pattern

Stock Holding

View Live Stock Screeners

Holding

Public

38.1

Promoter Holdings

61.57

FII

0.31

DII

0.0

Promoter Shares(Pledge Percentage)

0.0

Holding %

Pledges % of promoter shares %

MF Holding %

FII Holding %

Clinitech Laboratory Limited

Learn More About Stocks

Oil India Wins 9 Blocks in OALP Round-IX, Acreage Jumps 85%

IndusInd Bank Finds ₹1,979 Crore Net Worth Hit in Derivatives Audit

ICICI Lombard Q4 Profit Falls 1.9%, Declares ₹7 Final Dividend

CCI Approves Aster DM–Quality Care Merger; New Entity Named Aster DM Quality Care

About Clinitech Laboratory Limited

Companies Owned by Clinitech Laboratory Limited

Explore More Investment Options

Stocks

IPOs

MTF

US Stocks

Frequently Asked Questions

What is the Share Price of Clinitech Laboratory Ltd?

What is the Market Cap of Clinitech Laboratory Ltd?

What is the 52 Week High and Low of Clinitech Laboratory Ltd?

How to Buy Clinitech Laboratory Ltd share?